Development of novel compounds as Chemotherapeutic Drugs Targeting the MDM2-p53 Interaction

Gezen M., Taşkıran H., Tolay N., KARALI N. L., Erman B., Erman B.

Molbiyokon’18, Biomedicine and Genome Center, İzmir, Turkey, 5 - 08 September 2018, pp.62, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • City: İzmir
  • Country: Turkey
  • Page Numbers: pp.62
  • Istanbul University Affiliated: Yes